Gimatecan in Treating Patients With Recurrent or Progressive Primary Malignant Glioma
Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as gimatecan, work in different ways to stop
tumor cells from dividing so they stop growing or die.
PURPOSE: This phase I/II trial is studying the side effects and best dose of gimatecan in
treating patients with recurrent or progressive primary malignant glioma.